Home » Topics » Briefs » Other news to note

Other news to note
RSS

Novartis expands access to Ensemble Therapeutics' IL-17 antagonist program

May 25, 2016

PDL BioPharma commits to equity investment in Noden Pharma

May 25, 2016

Monsanto labels Bayer's acquisition proposal "incomplete and financially inadequate"

May 25, 2016

New company Thunderbolt Pharma acquires rights to Astellas' BAFF/APRIL antagonist program

May 25, 2016

Arbor Pharmaceuticals set to acquire XenoPort

May 24, 2016

Boehringer Ingelheim and Biomed X establish a global research team

May 24, 2016

Avalon Ventures and GSK form new company, PDI Therapeutics

May 23, 2016

Eisai reviews pipeline highlights of fourth quarter of fiscal 2015

May 23, 2016

Otsuka Pharmaceutical reviews pipeline highlights of first quarter 2016

May 23, 2016

Aptahem collaborates with Nencki Institute of Experimental Biology on APTA-1

May 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.